Stempeutics receives Japan process patent for its stem cell drug ‘Stempeucel’ – Financial Express

Stempeutics receives Japan process patent for its stem cell drug 'Stempeucel'Financial ExpressStempeutics Research, a group company of Manipal Education and Medical Group and a Joint Venture with Cipla Group, has been granted process patent from the Japan Patent Office (application no 2012-540529) for its novel stem-cell based drug
http://blog.zandcell.com/stempeutics-receives-japan-process-patent-for-its-stem-cell-drug-stempeucel-financial-express/